May 17, 2013

New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System

Kinetic Concepts, Inc. announced today that ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT) was associated with significantly improved patient outcomes compared to traditional Barker’s vacuum-packing technique (BVPT) in trauma and surgical patients studied. Results of the observational study, “Prospective"......

May 17, 2013

Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock

Quintiles today announced the completion of its initial public offering of 27,236,841 shares of its common stock at a price to the public of $40.00 per share. Quintiles offered and sold 13,125,000 shares of common stock in the offering and selling shareholders offered and sold 14,111,841"...

May 16, 2013

ASCO 2013: New Phase III data reveal targeted treatment with afatinib* or with nintedanib* improves progression-free survival in patients with advanced NSCLC

Growing body of clinical data supports superiority of the irreversible ErbB Family Blocker afatinib* over standard chemotherapy (with combination of cisplatin and gemcitabine or pemetrexed) for first-line treatment of patients with EGFR-mutation positive advanced NSCLC

May 16, 2013

Merck Serono and Quintiles Announce Innovative Clinical Development Partnership

Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, today announced a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services...

May 15, 2013

New evidence establishes EPA as highly predictive of skin graft failure and supports the utility of Systagenix WOUNDCHEK™ Protease Status point of care test in this application

New evidence presented on Wednesday 15th May 2013 at the European Wound Management Association (EWMA)’s conference in Copenhagen, revealed that elevated protease activity"......

May 13, 2013

Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services

Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services

MEDIVista MOBILE delivers services to Apple iPad and Android devices

eHealth Week

May 9, 2013

Coca-Cola Announces Global Commitments to Help Fight Obesity

The Coca-Cola Company today announces four global business commitments to further contribute to healthier, happier, and more active communities. These commitments, which apply to the more than 200 countries where we do business, are to:

1)"...

May 9, 2013

Quintiles Announces Pricing of Initial Public Offering

Quintiles today announced the pricing of its initial public offering of 23,684,210 shares of its common stock at a price to the public of $40.00 per share. The shares of Quintiles common stock are expected to begin trading on the New York Stock Exchange under the single-letter symbol "Q”"...

May 5, 2013

Covidien Announces 2013 Guidance and Provides Historical Financial Statements Adjusted for Discontinued Operations

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced revised 2013 guidance and released historical financial statements adjusted for the upcoming expected discontinued operations, reflecting the planned spin-off of its Pharmaceuticals business. These adjusted financial statements cover fiscal years 2010 to 2012 and the first quarter"......

May 2, 2013

Ferring Pharmaceuticals begins phase III trials of elobixibat, new compound with novel mechanism of action for chronic idiopathic constipation

Ferring Pharmaceuticals today announced it has initiated enrolment of patients in two phase III clinical trials of elobixibat for the treatment of chronic idiopathic constipation (CIC), a common gastrointestinal disorder affecting approximately 14% of the general population1. The two studies,"...